Y Kusunoki - Concepedia

Author

Y Kusunoki

Osaka Prefectural Medical Center

Also Known As

Kusunoki, Y., Y Kusunoki, Y. Kusunoki, Yoichiro Kusunoki

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

Osaka Prefectural Medical Center Osaka International Cancer Institute The University of Osaka Kinki Central Hospital

About

Y Kusunoki is an author at Osaka Prefectural Medical Center specializing in medicine, lung cancer, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	544
2	Health Sciences	2	2	62
3	Engineering	1	1	23
4	Natural Sciences	1	1	288
5	Cell Biology	1	1	288

Y Kusunoki

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Characterization of a mammalian mutant with a camptothecin-resistant DNA topoisomerase I. T Andoh, Kazuyuki Ishii, Yoshio Suzuki, Proceedings of the National Academy of Sciences ChromatinGenome InstabilityOncogenic AgentNatural SciencesRpmi 8402	1987	288
Phase I Study of Weekly Intravenous Infusions of CPT-11, a New Derivative of Camptothecin, in the Treatment of Advanced Non-Small-Cell Lung Cancer S. Negoro, M. Fukuoka, N Masuda, JNCI Journal of the National Cancer Institute	1991	274
CPT-11 in combination with cisplatin for advanced non-small-cell lung cancer. N Masuda, M. Fukuoka, M Takada, Journal of Clinical Oncology	1992	141
Sensitivity and specificity of lung cancer screening using chest low-dose computed tomography Yasuhiro Toyoda, Tomio Nakayama, Y Kusunoki, British Journal of Cancer	2008	119
Phase I and pharmacologic study of irinotecan in combination with cisplatin for advanced lung cancer N Masuda, M. Fukuoka, S. Kudoh, British Journal of Cancer Advanced Lung CancerOncologyMedicineBronchial NeoplasmPharmacotherapy	1993	94
Phase I study of irinotecan and cisplatin with granulocyte colony-stimulating factor support for advanced non-small-cell lung cancer. N Masuda, M. Fukuoka, Satoshi Kudoh, Journal of Clinical Oncology	1994	91
Phase I and pharmacologic study of irinotecan and etoposide with recombinant human granulocyte colony-stimulating factor support for advanced lung cancer. N Masuda, M. Fukuoka, Satoshi Kudoh, Journal of Clinical Oncology	1994	62
Phase II study of concurrent radiotherapy and chemotherapy for unresectable stage III non-small-cell lung cancer. Southern Osaka Lung Cancer Study Group. Kiyoyuki Furuse, Kaoru Kubota, Mutsuto Kawahara, Journal of Clinical Oncology	1995	61
Pro-gastrin-releasing peptide(31-98) as a tumour marker of small-cell lung cancer: comparative evaluation with neuron-specific enolase M Takada, Y Kusunoki, N Masuda, British Journal of Cancer Neuron-specific EnolaseTumor BiologyMedicinePharmacologyPathology	1996	60
CODE chemotherapy with and without granulocyte colony-stimulating factor in small-cell lung cancer M. Fukuoka, N Masuda, Shunichi Negoro, British Journal of Cancer MedicineImmunologyPathologySmall-cell Lung CancerBronchial Neoplasm	1997	51

Page 1